Drug class in one race
MAT2A drugs for Non-Small Cell Lung Cancer
2 tracked MAT2A drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the MAT2A page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 1/21 Phase 1
Head-to-head evidence: HSK41959 vs IDE397